ABVC BioPharma, Inc.
ABVC
$0.95
-$0.11-9.94%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 94.40K | 202.50K | 745.80K | 257.20K | 453.50K |
| Total Receivables | 165.80K | 196.30K | 763.40K | 2.69M | 1.42M |
| Inventory | -- | -- | -- | 11.50K | 11.50K |
| Prepaid Expenses | 151.60K | 250.00K | 346.60K | 447.30K | 195.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 645.50K | 661.80K | 688.10K |
| Total Current Assets | 411.70K | 648.80K | 2.50M | 4.07M | 2.77M |
|
|
|||||
| Total Current Assets | 411.70K | 648.80K | 2.50M | 4.07M | 2.77M |
| Net Property, Plant & Equipment | 14.58M | 14.65M | 14.75M | 12.42M | 8.67M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.92M | 2.59M | 1.93M | 1.93M | 1.96M |
| Total Assets | 19.40M | 19.73M | 21.06M | 21.18M | 16.24M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 3.13M | 3.13M | 3.20M | 3.04M | 3.10M |
| Short-term Debt | 324.80K | 89.00K | 755.80K | 1.74M | 1.30M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.16M | 1.13M | 1.12M | 571.00K | 695.30K |
| Total Finance Division Other Current Liabilities | 1.08M | 1.04M | 1.09M | 1.16M | 1.44M |
| Total Other Current Liabilities | 1.08M | 1.04M | 1.09M | 1.16M | 1.44M |
| Total Current Liabilities | 5.69M | 5.39M | 6.16M | 6.51M | 6.53M |
|
|
|||||
| Total Current Liabilities | 5.69M | 5.39M | 6.16M | 6.51M | 6.53M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 324.80K | 89.00K | 755.80K | 1.74M | 1.30M |
| Capital Leases | 1.41M | 1.51M | 1.60M | 164.10K | 177.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.20K | -- | -- | 12.00K | 41.70K |
| Total Liabilities | 7.13M | 6.90M | 7.76M | 6.68M | 6.75M |
|
|
|||||
| Common Stock & APIC | 97.75M | 97.18M | 96.03M | 93.14M | 86.40M |
| Retained Earnings | -79.16M | -78.42M | -76.86M | -73.30M | -72.05M |
| Treasury Stock & Other | -8.31M | -7.99M | -8.06M | -7.79M | -7.34M |
| Total Common Equity | 10.29M | 10.77M | 11.11M | 12.06M | 7.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.29M | 10.77M | 11.11M | 12.06M | 7.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 1.98M | 2.06M | 2.19M | 2.44M | 2.48M |
| Total Equity | 12.27M | 12.83M | 13.30M | 14.49M | 9.49M |
|
|
|||||